BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies

  • Post author:
  • Post category:uncategorized

BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service.